TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

109 hedge funds and large institutions have $18.3M invested in Tvardi Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

41% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 29

60% less capital invested

Capital invested by funds: $45.6M → $18.3M (-$27.2M)

Holders
109
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46K
Puts
$11K
Net Calls
Net Calls Change

Top Buyers

1
+$286K
2
+$280K
3
+$197K
4
Two Sigma Investments
Two Sigma Investments
New York
+$176K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$168K

Top Sellers

1
-$1.63M
2
-$1.43M
3
-$980K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$555K
5
PA
Pinnacle Associates
New York
-$473K
Name Holding Trade Value Shares
Change 		Change in
Stake
126
–
127
–
128
–
129
–
130
–
131
–
132
–
133
–
134
–
135
–
136
–
137
–
138
–
2 3 4 5
6